
Eli Lilly’s Acquisition of Scorpion Therapeutics
Overview of the Deal Acquirer: Eli Lilly and Company Target: Scorpion Therapeutics, Inc. Total Transaction Size: Up to $2.5 billion Upfront Payment: Approximately $1 billion Potential Milestone Payments: Up